VIR Projected Dividend Yield
Vir Biotechnology Inc ( NASDAQ : VIR )Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. Co.'s clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). Co.'s pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. 21 YEAR PERFORMANCE RESULTS |
VIR Dividend History Detail VIR Dividend News VIR Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |